An observational, prospective study to monitor effectiveness and safety of dual therapy of lamivudine plus lopinavir/ritonavir and darunavir/ritonavir in naïve and treatment-experienced HIV-positive patients in a real-world setting.
Phase of Trial: Phase IV
Latest Information Update: 02 Jan 2017
At a glance
- Drugs Lopinavir/ritonavir (Primary) ; Darunavir/ritonavir; Lamivudine
- Indications HIV infections
- Focus Adverse reactions; Therapeutic Use
- 02 Jan 2017 New trial record